aVenture — 2016 Investments
2 investments dated 2016 · listed companies and verified rows first · show all
CB Therapeutics builds a yeast platform for biosynthesis of molecules including psychedelics, cannabis, and alkaloids that are difficult to source through conventional methods.
AI & Machine LearningBiotechDeep TechHealthtechSan Diego, US
Sher Butt(Founder/CEO)inJacob Vogan(Founder)inJason (Zhen) Qi(Founder)Guoliang Yu(Executive Officer, Director)
BoardBing Zhu(Resignation effective upon this financing.)Alex Wu(Resignation effective upon this financing.)
Co-investorsJames Beshara FundMetaplanetY Combinator
ChargeItSpot offers ARC, a secure self-service kiosk and locker system that lets enterprise employees check out, store, and charge the devices they need for work.
Enterprise SoftwareHardwareIoTPhiladelphia, US
Douglas Baldasare(Executive Officer, Director)DOUGLAS BALDASARE(Executive Officer, Director)ROBERT KAY(Executive Officer)Robert Kay(Executive Officer)Harsh Agarwal(Executive Officer, Director)Peter Schmitt(Executive Officer, Director)
Co-investorsFusionX VenturesRobin Hood VenturesSoundboard Venture FundStart CapitalTIA VenturesSoundBoard Angel
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.